Search for Clinical Trials

Phase I study of autologous T lymphocytes expressing GD2-specific chimeric antigen and constitutively active IL-7 receptors for the treatment of…
  • Cancer - Brain
  • Cancer - All
  • Brain/Spinal Cord/Nervous System
Currently, there are over 15.5 million individuals who either have cancer or have had a history of cancer, and this population continues to…
  • Cancer - All
  • Cancer - Bladder
  • Cancer - Brain
  • Cancer - Breast
  • Cancer - Cervical
  • Cancer - Colon/Rectal
  • Cancer - Endometrial
  • Cancer - Esophagus
  • Cancer - Gastric/Stomach
  • Cancer - Head/Neck
  • Cancer - Hematology
  • Cancer - Kidney/Renal
  • Cancer - Leukemia
  • Cancer - Liver
  • Cancer - Lung
  • Cancer - Lymphoma
  • Cancer - Metastatic
  • Cancer - Myeloma
  • Cancer - Neuroblastoma
  • Cancer - Non-Hodgkin Lymphoma
  • Cancer - Pancreas
  • Cancer - Prostate
  • Cancer - Sarcoma
  • Cancer - Stem Cell Transplant
This is a Phase 1/2, open-label, multi-center trial to evaluate the safety, immunogenicity, and preliminary efficacy of INO-5401 and INO-9012 in…
  • Cancer - All
  • Cancer - Brain
NCI MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple…
  • Cancer - All
  • Cancer - Bladder
  • Cancer - Brain
  • Cancer - Breast
  • Cancer - Cervical
  • Cancer - Colon/Rectal
  • Cancer - Esophagus
  • Cancer - Gastric/Stomach
  • Cancer - Head/Neck
  • Cancer - Hematology
  • Cancer - Kidney/Renal
  • Cancer - Liver
  • Cancer - Lung
  • Cancer - Lymphoma
  • Cancer - Metastatic
  • Cancer - Myeloma
  • Cancer - Pancreas
  • Cancer - Prostate
The purpose of this study is to find the largest safe dose of HER2-CAR T cells, to learn what the side effects are, and to see whether this…
  • Geriatrics
  • Cancer - Brain
  • Cancer - All
Back to topback-to-top